The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing rapidly worldwide
as the obese and diabetic populations increase, and it has been estimated to be 20–30% in …

KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease - PMC Back
to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …

Nonalcoholic fatty liver disease (NAFLD) is currently the most common cause of chronic liver
disease in industrialized countries worldwide, and has become a serious public health issue …

This patient guideline is intended for all patients at risk of or living with non-alcoholic fatty
liver disease (NAFLD). NAFLD is the most frequent chronic liver disease worldwide and …

Since the publication of the guidelines for the assessment and management of non alcoholic
fatty liver disease (NAFLD) by the Asia–Pacific Working Party on NAFLD in 2007, 1 our …

These recommendations are based on the following:(1) a formal review and analysis of the
recently published world literature on the topic [Medline search up to June 2011];(2) the …

The current epidemic of non-alcoholic fatty liver disease (NAFLD) is reshaping the field of
hepatology all around the world. The widespread diffusion of metabolic risk factors such as …

Evidence‐based management guidelines for non‐alcoholic fatty liver disease (NAFLD) are
lacking in the Asia–Pacific region or elsewhere. This review reports the results of a …

Non-alcoholic fatty liver disease (NAFLD) has become one of the most common forms of
chronic liver disease in the Western world. The rise in NAFLD is thought to be associated …

This review of the literature consists of three sections. First, papers concerning non-alcoholic
fatty liver disease (NAFLD) awareness among the general population, general practitioners …